Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control

NCT01715311 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped withdrawn prior to patient recruitment

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Indacaterol
DRUG: Placebo to tiotropium
DRUG: Tiotropium
DRUG: Placebo to indacaterol

Sponsor

Novartis Pharmaceuticals